Successful Acquisitions

JUNE 27, 2023

Will Cava Going Public Set the Table for Other IPOs? By David Braun, Founder and CEO, Capstone Strategic When Washington DC based restaurant chain Cava became a publicly traded company recently, it bucked a trend that has lasted nearly two years, a notable absence of American IPOs.

IPO 111

IPO Initial Public Offering Public Trading Private Equity 111

TechCrunch: M&A

MAY 8, 2023

Content needs to be engaging and entertaining and you need to be recommended the right thing at the right time to keep you going. Barnes said that an IPO was part of the long-term plan but that “it’s not something we are targeting right now.” .” But there is still something missing in those takes, he continued.

Book-building 235

Book-building Funds IT Media 235

Mergers and Inquisitions

OCTOBER 4, 2023

There are some entertaining moments and good performances, so I wouldn’t call the movie “bad.” Everyone was locked up inside, and many turned to day trading for entertainment and money (in between binge-watching shows on streaming services). I wrote many articles about it. Remember when Chamath was on CNBC all the time ?

Finance 105

Finance Finance Retail Entertainment 105

Mergers and Inquisitions

DECEMBER 4, 2024

However, one common point across all the verticals is that IPOs are not common because there aren’t that many publicly traded sports teams, stadiums, or arenas. SPAC IPOs for esports companies were “hot” for a short period in 2021, but they seem to have died off by now.

Investment Banking 105

Investment Banking Bank Banking Investment 105

Cooley M&A

NOVEMBER 1, 2018

government shutdown disrupting the market for IPOs, Brexit uncertainty, natural disasters and various other crises, cross-border M&A activity momentum continues. In spite of a general environment of political and economic uncertainty and a daily sprinkling of stock market volatility, trade wars, sanctions, the U.S. Finally, with the U.K.

M&A 52

M&A Mergers and Acquisitions Business Government 52

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Growth Business

SEPTEMBER 13, 2023

DN Capital’s previous funds are top performers and the firm is one of the lead investors in companies such as Endeca (sold to Oracle), Shazam (one of the world’s leading mobile app), Auto1 (world’s largest used car marketplace), Purplebricks (IPO London) and Quandoo (sold to Recruit).

Capital 52

Capital Business Funds Investment 52